SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001362033-24-000001
Filing Date
2024-01-02
Accepted
2024-01-02 08:35:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 0001362033-24-00001.txt SC 13G 11917
  Complete submission text file 0001362033-24-000001.txt   13520
Mailing Address STRATTON HOUSE 5 STRATTON STREET LONDON X0 W1J 8LA
Business Address STRATTON HOUSE 5 STRATTON STREET LONDON X0 W1J 8LA 0011 44 207 959 8800
GSA CAPITAL PARTNERS LLP (Filed by) CIK: 0001362033 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1130
Type: SC 13G

Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91201 | Film No.: 24500395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)